Clinical Trials Logo

Parkinson's Syndrome clinical trials

View clinical trials related to Parkinson's Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT06370195 Not yet recruiting - Clinical trials for Parkinson's Syndrome

Effect of Stellate Ganglion Block on Drooling in Parkinson's Syndrome

Start date: April 2024
Phase: N/A
Study type: Interventional

This is a randomized controlled study, including dysphagic patients with Parkinson's syndrome who were received in the department of rehabilitation medicine. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 10-day treatment, Functional Oral Intake Scale, Drooling amount, depression are assessed.

NCT ID: NCT03667456 Completed - Parkinson Disease Clinical Trials

Evaluation of the Uses of a Digital-assisted Self-rehabilitation Device (TELE-PARK)

TELE-PARK
Start date: June 11, 2018
Phase: N/A
Study type: Interventional

Evaluate the use by the patient and his family and professional environment of a self-rehabilitation device with follow-up in tele-rehabilitation in people with Parkinson's disease taking into account the different actors within a health area (health professionals and paramedics in structure and in liberal).

NCT ID: NCT03638479 Completed - Parkinson Disease Clinical Trials

Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement Disorders

Start date: January 8, 2019
Phase:
Study type: Observational

This observational and experimental study seeks to establish a Smart Device System (SDS) to monitor high-resolution handtremor-based data using Smartphones, SmartWatches and Tablets. By doing this, movement data will be analyzed in depth with advanced statistical and Deep-Learning algorithms to identify new clinical phenotypical characteristics Parkinson's Disease and Essential Tremor.

NCT ID: NCT01950468 Withdrawn - Clinical trials for Parkinson's Syndrome

A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes

Start date: April 2017
Phase: Phase 3
Study type: Interventional

This is a phase 3, open-label, multiple-center, randomized cross-over study to assess the safety and efficacy of [123I]NAV5001 SPECT imaging in aiding in the differentiaion of parkinsonian syndromes from non-parkinsonian tremor.

NCT ID: NCT01950455 Terminated - Clinical trials for Parkinson's Syndrome

Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes

Start date: November 2013
Phase: Phase 3
Study type: Interventional

This is a phase 3, open-label, multiple-center, non-randomized single dose study to assess the safety and efficacy of [123I]NAV5001 SPECT imaging in aiding in the differentiaion of parkinsonian syndromes from non-parkinsonian tremor.